


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.18%
+0.51%
-2.36%
+105.37%
VTRS
Viatris
$10.67
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value
Chart
$10.17 (+4.92%)
$10.69 (-0.19%)
$8.89 (+20.02%)
$13.22 (-19.29%)
VTRS has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

VTRS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
VTRS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
VTRS Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayTBPH
17.52
-1.23%
PFE
25.20
-2.33%
NVS
131.98
+0.06%
INDV
30.39
+1.86%
PRFX
0.89
-3.95%
What is VTRS current stock price?
What are VTRS stock strengths?
What risks are associated with VTRS stock?
When is VTRS next earnings report?
What is VTRS market cap and volume?
What is VTRS's current Stock IQ?
Should I buy VTRS stock right now?
Is VTRS a Strong Buy right now?
What does a 'Strong Buy' rating mean for VTRS?
What does a 'Strong Sell' rating mean for VTRS?
What factors influence VTRS's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-1.18%
+0.51%
-2.36%
+105.37%
VTRS
Viatris
Current Price
$10.67
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value
Linked to VTRS
TBPH
17.52
-1.23%
PFE
25.20
-2.33%
NVS
131.98
+0.06%
INDV
30.39
+1.86%
PRFX
0.89
-3.95%

Chart
$10.17 (+4.92%)
$10.69 (-0.19%)
$8.89 (+20.02%)
$13.22 (-19.29%)
VTRS Analysts Opinion
VTRS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
VTRS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
VTRS Street Sentiment is extremely bullish and have positive views on the near-term outlook
VTRS has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels.
VTRS Latest Analysis
Tuesday Sector Leaders: Healthcare Energy. The best performing sector as of midday Tuesday is the Healthcare sector up 1.8%. Within the sector Viatris Inc (Symbol: VTRS) and Moderna Inc (Symbol: MRNA) are two large stocks leading the way showing a gain of 6.5% and 4.7% respectively. Among healthcare ETFs one ETF fo
Tue Nov 11, 2025
Viatris Inc. (VTRS) Presents at UBS Global Healthcare Conference 2025 Transcript.
Tue Nov 11, 2025
Theravances Q3 Earnings Surpass Estimates Revenues Match. TBPH delivers a third-quarter profit beating estimates and 19% revenue growth fueled by rising collaboration income from Viatris related to Yupelri sales.
Tue Nov 11, 2025
Viatris Inc. (NASDAQ:VTRS) Q3 2025 Earnings Call Transcript. Viatris Inc. (NASDAQ:VTRS) Q3 2025 Earnings Call Transcript November 6 2025 Viatris Inc. beats earnings expectations. Reported EPS is $0.67 expectations were $0.63. Operator: Good morning and welcome to the Viatris Q3 2025 Earnings Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Bill [….]
Fri Nov 7, 2025
Viatris (VTRS) Beats Q3 Earnings and Revenue Estimates. Viatris (VTRS) delivered earnings and revenue surprises of 6.35% and 3.09% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Thu Nov 6, 2025
Viatris Tops Q3 Earnings & Revenue Estimates Ups 25 Guidance . Viatris tops Q3 earnings and revenue estimates lifts 2025 outlook and expands its Japan presence with Aculys Pharma deal.
Thu Nov 6, 2025
Viatris raises outlook as emerging markets drive Q3 beat.
Thu Nov 6, 2025
Viatris Non-GAAP EPS of $0.67 beats by $0.05 revenue of $3.76B beats by $160M.
Thu Nov 6, 2025
Countdown to Viatris (VTRS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS. Evaluate the expected performance of Viatris (VTRS) for the quarter ended September 2025 looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Wed Nov 5, 2025
Viatris Q3 Earnings Preview: Eyes on debt pipeline amid stock slump.
Wed Nov 5, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
VTRS Stock trends
VTRS Stock performance
VTRS Stock analysis
VTRS investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.